EUVIMEDOpdag EUVIMED
FallberichtOpen access · CC BY-NC-ND 4.0

Urinary bladder hemangiosarcoma in a cat treated with partial cystectomy and adjuvant metronomic cyclophosphamide and thalidomide

Abigail McNally, Matteo Rossanese iD, Alejandro Suárez-Bonnet iD, Alexandros Hardas iD, Andrew D Yale iD

Journal of Veterinary Internal Medicine · 2023-07-01 · 37 (4) · 1488-1492

DOI: 10.1111/jvim.16750 ↗

At a glance

Fallbericht in Journal of Veterinary Internal Medicine, published online on 2023-07-01. Written by Abigail McNally and 4 co-authors. Institution: Department of Clinical Science and Services, The Royal Veterinary College, North Mymms, Hatfield, Hertfordshire AL9 7TA, United Kingdom. Major MEDLINE topics: Hemangiosarcoma, Cat Diseases, Urinary Bladder Neoplasms. Cited 6 times so far (Crossref); 27 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Visceral hemangiosarcomas (HSA) are rare in cats and typically associated with aggressive biologic behavior and poor prognosis. A 4-year-old male neutered domestic shorthair cat was presented with a 3-month history of hematuria and stranguria; ultrasonography identified a large bladder mass. Complete excision was achieved by partial cystectomy. Histopathology and immunohistochemistry for von Willebrand factor confirmed HSA. The cat was treated using adjuvant cyclophosphamide, thalidomide, and meloxicam for 8 months. Abdominal ultrasonography repeated at 2 months and computed tomography repeated at 5 and 19 months after diagnosis showed no evidence of local recurrence or metastasis. The cat was alive at last follow-up (896 days). Although the cat described in this report experienced a more favorable prognosis compared to other visceral HSA locations, additional cases are needed to further understand the biological behavior of bladder HSAs and guide treatment decisions.

Subjects

MeSH terms (MEDLINE)

HemangiosarcomaCat DiseasesUrinary Bladder NeoplasmsMaleCatsAnimalsUrinary BladderCystectomyThalidomideCyclophosphamideAdjuvants, Immunologic

Author keywords

catneoplasiaoncologyveterinary

Substances

ThalidomideCyclophosphamideAdjuvants, Immunologic

Authors and institutions

  • Department of Clinical Science and Services, The Royal Veterinary College, North Mymms, Hatfield, Hertfordshire AL9 7TA, United Kingdom.
  • Department of Pathobiology & Population Sciences, The Royal Veterinary College, North Mymms, Hatfield, Hertfordshire AL9 7TA, United Kingdom.

ORCID profiles: Matteo Rossanese, Alejandro Suárez-Bonnet, Alexandros Hardas, Andrew D Yale

Cite

APA

McNally, A., Rossanese, M., Suárez-Bonnet, A., Hardas, A., & Yale, A. D. (2023). Urinary bladder hemangiosarcoma in a cat treated with partial cystectomy and adjuvant metronomic cyclophosphamide and thalidomide. Journal of Veterinary Internal Medicine, 37(4), 1488-1492. https://doi.org/10.1111/jvim.16750

Vancouver

McNally A, Rossanese M, Suárez-Bonnet A, Hardas A, Yale AD. Urinary bladder hemangiosarcoma in a cat treated with partial cystectomy and adjuvant metronomic cyclophosphamide and thalidomide. Journal of Veterinary Internal Medicine. 2023;37(4):1488-1492. doi:10.1111/jvim.16750

BibTeX
@article{McNally2023,
  author = {McNally, Abigail and Rossanese, Matteo and Suárez-Bonnet, Alejandro and Hardas, Alexandros and Yale, Andrew D},
  title = {Urinary bladder hemangiosarcoma in a cat treated with partial cystectomy and adjuvant metronomic cyclophosphamide and thalidomide},
  journal = {Journal of Veterinary Internal Medicine},
  year = {2023},
  volume = {37},
  number = {4},
  pages = {1488--1492},
  doi = {10.1111/jvim.16750}
}
Start for free →